Borderline Ovarian Mucinous Tumor

specific

A low grade mucinous epithelial neoplasm arising from the ovary. It is characterized by an atypical proliferation of mucinous-type epithelial cells without evidence of stromal invasion. The mucinous epithelial cells may be of intestinal or endocervical type.

Centers

Active Trials

—

Cancer Funding

Top Centers for Borderline Ovarian Mucinous Tumor(28)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program	Active Research Program	1	—	51.8
2	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	51.8
3	Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program	Active Research Program	1	—	51.8
4	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	1	—	51.8
5	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	51.8
6	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program	Active Research Program	1	—	51.8
7	USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program	Active Research Program	1	—	51.8
8	University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program	Active Research Program	1	—	51.8
9	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program	Active Research Program	1	—	51.8
10	UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program	Active Research Program	1	—	51.8
11	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	1	—	51.8
12	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive Active Research Program	Active Research Program	1	—	51.8
13	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	1	—	51.8
14	Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program	Active Research Program	1	—	51.8
15	Cleveland Clinic Cancer CenterCleveland, OH Active Research Program	Active Research Program	1	—	51.8
16	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	1	—	51.8
17	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	1	—	51.8
18	University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical Active Research Program	Active Research Program	1	—	51.8
19	University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program	Active Research Program	1	—	51.8
20	UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program	Active Research Program	1	—	51.8
21	Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX Active Research Program	Active Research Program	1	—	51.8
22	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	1	—	51.8
23	Stony Brook Cancer CenterStony Brook, NY Active Research Program	Active Research Program	1	—	51.8
24	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	1	—	51.8
25	Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program	Active Research Program	1	—	51.8
26	Upstate Cancer CenterSyracuse, NY Active Research Program	Active Research Program	1	—	51.8
27	University of Texas Medical Branch Cancer CenterGalveston, TX Active Research Program	Active Research Program	1	—	51.8
28	Louisiana Cancer Research CenterNew Orleans, LA Active Research Program	Active Research Program	1	—	51.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →